Home
Conditions
Skin Neoplasms

Clinical trial condition

Skin Neoplasms

Explore clinical trials studying Skin Neoplasms. Study availability and eligibility vary by location and protocol.

2,110 public trials 360 recruiting studies

Refine in advanced search Browse all conditions

Skin Neoplasms trial results

Recruiting

Comparing Tunlametinib Capsules and Combination Chemotherapy in Advanced NRAS-mutant Melanoma

NCT06008106

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Beijing Cancer Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors

NCT03755739

Conditions: Adenocarcinoma, Adnexal Diseases, Breast Cancer, +65 more
Locations: The Second Affiliated Hospital of Guangzhou Medical University Guanzhou, Guangdong, China

View Trial Details

Recruiting

Immunological Functionnal Test Validation to Predict Melanoma Metastatic Patient Response to Checkpoint Inhibitors

NCT05649683

Conditions: Melanoma, Melanoma (Skin), Neoplasms, +10 more
Locations: CHU de Nice - Hôpital de l'Archet Nice, Alpes-maritimes, France

CHU de Montpellier Montpellier, Occitanie, France

CHRU de Lille Lille, France

View Trial Details

Recruiting

Biobank and Register of Patients With Agresive Tumors for Translational and Analytical Research

NCT05539677

Conditions: Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +46 more
Locations: N.N. Petrov NMRC of Oncology, Oncoimmunology dep. Saint Petersburg, Russia

View Trial Details

Recruiting

Neoadjuvant Combination Immunotherapy for Stage III Melanoma

NCT03842943

Conditions: Cutaneous Melanoma, Melanoma, Neoplasms, +10 more
Locations: University of Louisville Louisville, Kentucky, United States

View Trial Details

Recruiting

Evaluating the Effect of Nivolumab for Patients With In-transit Metastases Treated With Isolated Limb Perfusion

NCT03685890

Conditions: In-Transit Metastasis, Melanoma, Neoplasms, +10 more
Locations: Netherlands Cancer Institute Amsterdam, Netherlands

Erasmus MC Cancer Institute Groningen, Netherlands

Erasmus MC Cancer Institute Rotterdam, Netherlands

Sahlgrenska University Hospital Gothenburg, Sweden

View Trial Details

Recruiting

GM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid Tumors

NCT06265025

Conditions: Adenocarcinoma, Breast Cancer, Breast Diseases, +47 more
Locations: National Cancer Center Goyang-si, Gyeonggi-do, South Korea

Korea University Anam Hospital Seoul, South Korea

Hanyang University Seoul Hospital Seoul, South Korea

Severance Hospital, Yonsei University Health System Seoul, South Korea

View Trial Details

Recruiting

Phase II Trial of Neoadjuvant and Adjuvant IO102-IO103 and Pembrolizumab KEYTRUDA® in Patients With Resectable Tumors

NCT05280314

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +14 more
Locations: Yale New Haven, Connecticut, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

Massey Cancer Center Richmond, Virginia, United States

Melanoma Institute Australia The Uiniversity of Sydney, and Royal North Shore Hospital Sydney, New South Wales, Australia

View all 15 locations

View Trial Details

Recruiting

Profiling of Circulating Immune Cells to Uncover Response Signatures to Anti-PD1 Immunotherapy in Melanoma Patients

NCT06154668

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: CHU Grenoble Alpes Grenoble, France

View Trial Details

Recruiting

Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies

NCT04282044

Conditions: Adenocarcinoma, Adnexal Diseases, Breast Diseases, +64 more
Locations: HonorHealth Research Institute Scottsdale, Arizona, United States

UC San Diego Moores Cancer Center La Jolla, California, United States

Stanford University Stanford, California, United States

View Trial Details

Skin Neoplasms

Skin Neoplasms trial results

Related conditions